aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
jueves, 9 de mayo de 2024
Save the Date: September 17 AHRQ CAHPS Research Meeting on Patient-Reported Experience and Outcome Measures in Research and Clinical Practice
Save the Date! Sept. 17 — Virtual Research Meeting on “Patient-Reported Experience and Outcome Measures in Research and Clinical Practice”
Date: Tuesday, September 17, 2024
Time: 11 a.m. – 4 p.m. ET
On September 17, AHRQ’s Consumer Assessment of Healthcare Providers and Systems (CAHPS®) program will host a free virtual research meeting to explore the differences between patient-reported experience measures (PREMs) and patient-reported outcome measures (PROMs), how they are connected, and how they can be used to measure and improve the quality and value of healthcare.
The CAHPS Research Meeting will share current research on the following questions:
What are the differences between PREMs and PROMs?
How are PREMs and PROMs interconnected?
How can PREMs and PROMs best be used to improve quality and promote value-based healthcare?
What are future directions for PREMs and PROMs research and use in clinical practice?
Eugene Nelson, Sc.D., Professor of Community and Family Medicine at the Geisel School of Medicine at Dartmouth, will present the keynote address on “How Patient Experience and Patient-Reported Outcome Measures Are Interconnected.”
The CAHPS Research Meeting is open to the public. AHRQ invites CAHPS survey users, researchers, healthcare organization leaders, patient advocates, policymakers, federal partners, and others interested in the relationship between PREMs and PROMs. Registration details will be available this summer.
For questions, please contact the CAHPS User Network at cahps1@westat.com or 1-800-492-9261.
Patients' perspectives on quality and patient safety failures: lessons learned from an inquiry into transvaginal mesh in Australia. May 8, 2024
https://psnet.ahrq.gov/issue/patients-perspectives-quality-and-patient-safety-failures-lessons-learned-inquiry
Patients' perspectives on quality and patient safety failures: lessons learned from an inquiry into transvaginal mesh in Australia.
Motamedi M, Degeling C, M. Carter S. BMC Health Serv Res. 2024;24(1):436.
Women patients experience medical gaslighting wherein clinicians, policy makers, or the public do not believe their lived experiences. This article details more than 400 accounts submitted by women who were harmed by transvaginal mesh, and how their harm was exacerbated by dismissals by their physicians and regulatory bodies.
Application of trigger tools for detecting adverse drug events in older people: a systematic review and meta-analysis. May 8, 2024
https://psnet.ahrq.gov/issue/application-trigger-tools-detecting-adverse-drug-events-older-people-systematic-review-and
Application of trigger tools for detecting adverse drug events in older people: a systematic review and meta-analysis.
Schiavo G, Forgerini M, Varallo FR, et al. Res Social Adm Pharm. . 2024;Epub Mar 22.
Adverse drug events (ADE) are common in older adults. This systematic review identified 12 trigger tools for detecting ADE in older adults. Trigger tools designed or adapted for the older adult population performed better than those designed for the general population. Most studies assessed performance using positive predictive value (PPV), but there was no consensus of what constitutes a good or poor PPV.
Comparative evaluation of LLMs in clinical oncology. May 8, 2024
https://psnet.ahrq.gov/issue/comparative-evaluation-llms-clinical-oncology
Comparative evaluation of LLMs in clinical oncology.
Rydzewski NR, Dinakaran D, Zhao SG, et al. NEJM AI. 2024;1(5):AIoa2300151.
Large language models (LLM) are being developed to improve diagnostic accuracy. This study compared five LLMs on their accuracy of oncology diagnoses. Accuracy ranged from no better than random chance to similar to resident physicians. Notably, all models exhibited poor performance on women-predominant malignancies, suggesting a bias in training materials. This highlights the importance of partnerships between developers and medical professionals to co-develop reliable training sets.
Entangled in complexity: an ethnographic study of organizational adaptability and safe care transitions for patients with complex care needs. May 8, 2024
https://psnet.ahrq.gov/issue/entangled-complexity-ethnographic-study-organizational-adaptability-and-safe-care-transitions
Entangled in complexity: an ethnographic study of organizational adaptability and safe care transitions for patients with complex care needs.
Hedqvist A‐T, Praetorius G, Ekstedt M, et al. J Adv Nurs. 2024;Epub Apr 20.
Transitions of care are a vulnerable time for all patients and especially older adults with complex care needs. Utilizing document review, observations, and interviews, this study describes how inconsistencies in timing and precision at the time of transition put patients at risk. Examples include early discharge from hospital due to crowding, insufficient assessment of activities of daily living, and incomplete transfer of information. A safe care transition pathway describes critical steps to ensure safe transitions.
1-hr "Live" CME/AAPA/CNE/CPE/CPT/CPH Webinar on: Fraudulent Drugs: You’re Using What? sponsored by the Division of Drug Information
https://fda.zoomgov.com/webinar/register/WN_2MGQ6v7nRN6cYr2LKwb_BA?utm_medium=email&utm_source=govdelivery#/registration
Description: This series of educational webinars is designed to aid physicians, physician assistants, nurse practitioners, nurses, pharmacists, pharmacy technicians, certified public health professionals, other health care professionals, and students, to provide better patient care by knowing how to find relevant FDA regulatory information that will improve drug safety. There is a whole universe of unusual products available to consumers that claim to do everything from improve your mood, lose weight, prevent illness, or cure serious diseases. Some are relatively harmless; others could cause serious injuries or even death. The goal of this presentation is to give healthcare practitioners some insights into some of the more common product types that your patients may currently be using or may resort to depending on the situation. The topics of discussion will include quick cures, chronic conditions, cough/cold/COVID, caustic topicals, and lifestyle/recreational drugs.
miércoles, 8 de mayo de 2024
AHRQ Challenge on Designing the Optimal Future State of CDS Connect
AHRQ Challenge on Designing the Optimal Future State of CDS Connect: The winners of the CDS Connect Challenge are announced.
The CDS Connect Project is a freely available web-based platform that enables the clinical decision support (CDS) community to identify evidence-based care, translate and codify information into an interoperable health IT standard, and leverage tooling to promote a collaborative model of CDS development.
https://cds.ahrq.gov/cdsconnect
Resources and Tools on Patient and Healthcare Workforce Safety
Resources and Tools on Patient and Healthcare Workforce Safety: This curated list of resources aligns with the four foundational areas identified by the National Action Plan. These resources will help address many of the issues identified in a safety assessment.
National Action Alliance: Webinars May 21 from noon to 1:00 p.m. ET
National Action Alliance: Webinars
Upcoming Webinars
Registration is open for a webinar on May 21 from noon to 1:00 p.m. ET to highlight progress made by the National Action Alliance for Patient and Workforce Safety. The topic is Understanding and Operationalizing the National Action Alliance Aim #1: Advance Organizational Safety Strategies Using National Action Plan Foundations.
Workplace Safety Supplemental Item Set for Hospital SOPS
Workplace Safety Supplemental Item Set for Hospital SOPS: The SOPS® Workplace Safety Supplemental Items for the Hospital Survey were developed and pilot tested for use with the core SOPS Hospital Survey to help hospitals assess the extent to which their organization’s culture supports workplace safety for providers and staff.
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast) Thursday, May 23, 2024 3:30 – 4:30 p.m. EDT
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast): This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their member organizations’ survey results, how SOPS resources were used, and their focus on initiatives to address workplace safety, including burnout. Recent research about the relationship between hospital workplace safety and patient safety culture, job satisfaction, and intent to leave was also shared.
The Effect of Protein Intake on Health: A Systematic Review
The Effect of Protein Intake on Health: A Systematic Review: This report reviews the association between dietary protein intake and bone disease, kidney disease, and sarcopenia risks, aiming to inform updates to the protein DRIs, including a new reference value for chronic disease risk reduction.
Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review
Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review: This report reviews the evidence on the average daily dietary protein and individual indispensable amino acid intake requirement of apparently healthy individuals by life stage and sex. We considered evidence published since the current DRIs were set and our findings will serve as a key reference for future updates to the DRIs for protein and amino acids.
Fatigue and Sleepiness of Clinicians Due to Hours of Service
Fatigue and Sleepiness of Clinicians Due to Hours of Service: The purpose of this rapid response is to summarize the most relevant and recent literature on PSPs focused on fatigue and sleepiness of clinicians related to hours of service and how these PSPs can be implemented. The report should be of interest to healthcare system and hospital leaders who are wrestling with concerns about clinician burnout.
martes, 7 de mayo de 2024
CDER Quantitative Medicine Center of Excellence (QM CoE)
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/cder-quantitative-medicine-center-excellence-qm-coe?utm_medium=email&utm_source=govdelivery#:~:text=The%20Center%20for%20Drug%20Evaluation,regulatory%20decision%2Dmaking%20across%20CDER.
FDA’s CDER Establishes New Quantitative Medicine Center of Excellence
The U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is pleased to announce the new CDER Quantitative Medicine (QM) Center of Excellence (CoE).
QM involves the development and application of exposure-based, biological, and quantitative modeling and simulation approaches derived from nonclinical, clinical, and real-world sources to inform drug development, regulatory decision-making, and patient care. This new CoE will bring together staff and leadership from the Office of Generic Drugs, Office of New Drugs, Office of Pharmaceutical Quality, and Office of Translational Sciences in CDER. The goal of this CDER QM CoE is to facilitate and coordinate the continuous evolution and consistent application of QM across the Center.
CDER’s QM CoE will conduct the following activities:
Spearhead QM-related policy development and best practices to facilitate the consistent use of QM approaches during drug development and regulatory assessment
Facilitate systematic outreach to scientific societies, patient advocacy groups, and other key stakeholders
Coordinate CDER’s efforts around QM education and training
Drug development is a multifaceted, complex, high-risk endeavor involving a range of scientific, financial, and regulatory challenges. Innovative technologies, tools, and approaches are increasingly utilized to improve drug development efficiency throughout the lifecycle, address complex issues and enable optimized treatments reaching patients. By fostering integration of QM approaches across CDER, the CoE can help advance therapeutic medical product development and inform regulatory decision-making. As a result, the QM CoE is expected to help streamline and accelerate drug development and speed the delivery of safe, effective, therapeutically optimized medicines to the public.FDA’s CDER Establishes New Quantitative Medicine Center of Excellence
The U.S. Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is pleased to announce the new CDER Quantitative Medicine (QM) Center of Excellence (CoE).
QM involves the development and application of exposure-based, biological, and quantitative modeling and simulation approaches derived from nonclinical, clinical, and real-world sources to inform drug development, regulatory decision-making, and patient care. This new CoE will bring together staff and leadership from the Office of Generic Drugs, Office of New Drugs, Office of Pharmaceutical Quality, and Office of Translational Sciences in CDER. The goal of this CDER QM CoE is to facilitate and coordinate the continuous evolution and consistent application of QM across the Center.
CDER’s QM CoE will conduct the following activities:
Spearhead QM-related policy development and best practices to facilitate the consistent use of QM approaches during drug development and regulatory assessment
Facilitate systematic outreach to scientific societies, patient advocacy groups, and other key stakeholders
Coordinate CDER’s efforts around QM education and training
Drug development is a multifaceted, complex, high-risk endeavor involving a range of scientific, financial, and regulatory challenges. Innovative technologies, tools, and approaches are increasingly utilized to improve drug development efficiency throughout the lifecycle, address complex issues and enable optimized treatments reaching patients. By fostering integration of QM approaches across CDER, the CoE can help advance therapeutic medical product development and inform regulatory decision-making. As a result, the QM CoE is expected to help streamline and accelerate drug development and speed the delivery of safe, effective, therapeutically optimized medicines to the public.
Join SAMHSA’s Webinar about BestPractices4Data: Sharing Innovations and Best Practices for Grantees, from Grantees Tuesday, June 6, 2 – 3 p.m. ET
https://westat.zoomgov.com/webinar/register/WN_RGDNSq8fSKib2gl0Q2p8yQ?utm_source=SAMHSA&utm_campaign=a557a6da7f-EMAIL_CAMPAIGN_2024_05_03_02_02&utm_medium=email&utm_term=0_-a557a6da7f-%5BLIST_EMAIL_ID%5D#/registration
SAMHSA is releasing BestPractices4Data: Sharing Innovation and Best Practices for Grantees, from Grantees, a series of six issue briefs along with a webinar that focuses on sharing innovations and best practices for grantees, from grantees.
BestPractices4Data Series of Issue Brief Topics:
Incorporate Technology for Data Collection and Reporting
Use Data to Monitor Progress and Tell Your Agency Story
Establish Data Protocols to Optimize Data Collection
Hire Effectively for Data Roles
Manage Data Collection for Multiple SAMHSA Grants
Understand Unique Data Concerns When Working with Tribes
In 2023, the Substance Abuse and Mental Health Services Administration (SAMHSA) convened listening sessions with grantees and government project officers to learn about strategies that grantees use to optimize data collection processes. Produced by SAMHSA’s Center for Financing Reform and Innovation (CFRI) contract, the series of six issue briefs aims to improve efficiency in the use of grant funds by providing opportunities for grantees to learn from each other. The BestPractices4Data series of issue briefs and webinar brings together innovative and best practices that grantees use to address the most common, complex, and costly challenges associated with grantee required data collection activities.
Featured Presenters:
Shoma Ghose, Associate Vice President, Westat – Welcome, Introduction of Panelists, Closing Remarks
Naomi Tomoyasu, Director of the Center for Behavioral Health Statistics and Quality, SAMHSA – Opening Remarks
David Barry, Director of the Division of Suicide Prevention and Community Supports, Center for Mental Health Services, SAMHSA – Report Overview
Howard Goldman, Professor of Psychiatry, University of Maryland – Moderator
Christopher Clukay, Data Analyst, Mental Health Center of Greater Manchester – Panelist
Brooke Tolle, Tribal Opioid Response (TOR) Grant Data Coordinator, Chickasaw Nation Department of Health – Panelist
Kim Truong, Lead Certified Community Behavioral Health Clinics (CCBHC) Grant Evaluator, Greater Nashua Mental Health – Panelist
First Responders and Disaster Responders Resource Portal
https://www.samhsa.gov/dtac/disaster-responders?utm_source=SAMHSA&utm_campaign=46ffe3b7c0-EMAIL_CAMPAIGN_2024_05_06_03_41&utm_medium=email&utm_term=0_-46ffe3b7c0-%5BLIST_EMAIL_ID%5D
Developed by the SAMHSA Disaster Technical Assistance Center (DTAC), this website explores the higher risk of mental illness and substance use disorders that first responders and disaster responders face. It provides tips for deployment, stress management for responders, online trainings, SAMHSA DTAC publications for first responders, and many other resources.
A Guide to Managing Stress for Disaster Responders and First Responders
https://store.samhsa.gov/product/guide-managing-stress-disaster-responders-and-first-responders/pep22-01-01-003?utm_source=SAMHSA&utm_campaign=46ffe3b7c0-EMAIL_CAMPAIGN_2024_05_06_03_41&utm_medium=email&utm_term=0_-46ffe3b7c0-%5BLIST_EMAIL_ID%5D
This SAMHSA DTAC guide has tips and information on how to manage stress for disaster and first responders. The guide provides information on the stress cycle, managing personal crises/risk of suicide, and self-care for responders. The guide also offers resources including a crisis lifeline, a website on coping with traumatic events from the National Institute of Mental Health, and many more.
First Responders: Behavioral Health Concerns, Emergency Response, and Trauma
https://www.samhsa.gov/sites/default/files/dtac/supplementalresearchbulletin-firstresponders-may2018.pdf?utm_source=SAMHSA&utm_campaign=46ffe3b7c0-EMAIL_CAMPAIGN_2024_05_06_03_41&utm_medium=email&utm_term=0_-46ffe3b7c0-%5BLIST_EMAIL_ID%5D
This edition of the SAMHSA DTAC Supplemental Research Bulletin provides detailed background information on first responders and behavioral health concerns unique to this group, risk factors, and interventions to help protect the behavioral health of first responders.
The Effects of Trauma on First Responders
https://www.samhsa.gov/sites/default/files/dtac/dialogue-vol14-is1_final_051718.pdf?utm_source=SAMHSA&utm_campaign=46ffe3b7c0-EMAIL_CAMPAIGN_2024_05_06_03_41&utm_medium=email&utm_term=0_-46ffe3b7c0-%5BLIST_EMAIL_ID%5D
Developed by SAMHSA DTAC, this issue of The Dialogue focuses on first responder mental health and trauma through several articles written by first responders. Contributors include a firefighter, an emergency physician, and a critical care paramedic. Topics include self-care tips, posttraumatic stress disorder, how to handle survivor reactions, and the role of behavioral health in disaster response.
lunes, 6 de mayo de 2024
SOPS Databases
SOPS Databases: The Surveys on Patient Safety Culture (SOPS) Databases serve as a central repository for SOPS survey data.
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast)
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast): This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their member organizations’ survey results, how SOPS resources were used, and their focus on initiatives to address workplace safety, including burnout. Recent research about the relationship between hospital workplace safety and patient safety culture, job satisfaction, and intent to leave was also shared.
Racial and Ethnic Disparities in All-Cause and Cause-Specific Mortality Among US Youth
Racial disparities in death rates widening for U.S. children & teens
Black children, indigenous children, and other youth of color die from all injuries and diseases at disproportionately higher rates than white youth, according to a new study in JAMA. And the disparities are widening — between 2014 and 2020, the overall death rate among Black youth increased 37%, while only increasing 5% for white youth.
The disparities persist across deaths from illness and injuries. Between 2016 and 2020, seven times as many Black youth died from asthma than white youth, and 10 times as many were murdered. In the same time span, the suicide rate for American Indian or Alaskan Native youth was more than two and a half times the rate for white youth.
Researchers compared mortality rates for youth ages 1 to 19 using a national CDC database. They noted that between 2019 and 2021, the overall pediatric mortality rate increased by more than 18% — an increase mainly driven by homicides, suicide, and car crashes (Covid played only a small role). Firearms and crashes were the leading factors in widening racial disparities, with firearm injuries as the leading cause of death for all children and teens. The findings indicate that efforts to address gun violence will be needed to address racial disparities, the authors write.
https://jamanetwork.com/journals/jama/fullarticle/2818483?guestAccessKey=964d2832-89ff-4409-a3a0-b96e343165cb&utm_term=050424&utm_campaign=ftm_links&utm_medium=referral&_hsenc=p2ANqtz-9WfpXo793qr-_Ol0-InmvDFOkMJoXuHx6wuWiiUw4ZYkeh5MIuA_9fefjJwtha333IOPvYFRg3RXnchMuQtXkKnRDdRw&_hsmi=305565684&utm_content=tfl&utm_source=For_The_Media
Juul spent big to court Black leaders to promote its e-cigarettes, new documents show Nicholas Florko By Nicholas Florko Feb. 3, 2024
Juul spent big to court Black leaders to promote its e-cigarettes, new documents show
Nicholas Florko
By Nicholas Florko Feb. 3, 2024
https://www.statnews.com/2024/02/03/juul-courting-black-leaders-promote-e-cigarettes/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--Tj0_vqGVUnxrY-2zfLbhbCCdTGCaWPtu9ATMcCUebKv9uYgeiM-NfdY1PVUCnymzUAET4SS0bM0to3kVTh4gVSZHPxw&_hsmi=305565684&utm_content=305565684&utm_source=hs_email
In the midst of the youth vaping crisis, two prominent experts — NYU professors David Abrams and Ray Niaura — defended vaping as an effective smoking-cessation strategy, even before Congress. But a STAT investigation found that both failed to disclose extensive involvement with vape manufacturer Juul, including coordinating on public talking points, participating in scientific advisory board meetings, and dining with executives.
The documents don’t provide evidence that the work was paid, but conflict of interest experts say the conflict should have been disclosed, reports STAT’s Nick Florko. Both professors said that they did not advise Juul, but Abrams wrote in an email that “in retrospect we should have disclosed the potential conflicts.” Read more about the researchers’ ties and how journals that have published their work have reacted.
NYU professors who defended vaping didn’t disclose ties to Juul, documents show
Nicholas Florko
By Nicholas Florko
https://www.statnews.com/2024/05/06/juul-vaping-advocates-nyu-professors-non-disclosed-conflict-interest/?utm_campaign=morning_rounds&utm_medium=email&_hsenc=p2ANqtz--sEy83KRkXs_rHpUlnUeDk6_SIieq3cXH5BC3LS92nzmVs-uiycMaGf1paoySymTd9Ylui0FwuyYmfmcgNQ6thsSsy4w&_hsmi=305565684&utm_content=305565684&utm_source=hs_email
May 6, 2024
CDER Quantitative Medicine Center of Excellence (QM CoE)
https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/cder-quantitative-medicine-center-excellence-qm-coe
About the Quantitative Medicine Center of Excellence (QM CoE)
https://www.fda.gov/about-fda/cder-quantitative-medicine-center-excellence-qm-coe/about-quantitative-medicine-center-excellence-qm-coe
Quantitative Medicine Center of Excellence (QM CoE) Training
https://www.fda.gov/about-fda/cder-quantitative-medicine-center-excellence-qm-coe/quantitative-medicine-center-excellence-qm-coe-training
domingo, 5 de mayo de 2024
Annual Diagnostic Excellence Summit. May 22, 2024
The Armstrong Institute Center for Diagnostic Excellence. Johns Hopkins University, Baltimore, MD, May 22, 2024, 9:00 AM-4:00 PM (eastern).
Diagnostic excellence must be tracked to enable and inform lasting improvement. The theme of this annual event is “From Data to Implementation”. The importance of diagnostic excellence measurement and enhancing equity in measurement processes are amongst the topics to be covered.
https://psnet.ahrq.gov/issue/annual-diagnostic-excellence-summit
sábado, 4 de mayo de 2024
Supporting error management and safety climate in ambulatory care practices: the CIRSforte study. May 1, 2024
https://psnet.ahrq.gov/issue/supporting-error-management-and-safety-climate-ambulatory-care-practices-cirsforte-study
Supporting error management and safety climate in ambulatory care practices: the CIRSforte study.
Müller BS, Lüttel D, Schütze D, et al. J Patient Saf. 2024;Epub Mar 18.
Patient safety in ambulatory care settings is receiving increasing attention. This study evaluated an error management and safety climate intervention implemented across 184 ambulatory practices in Germany. The intervention included email newsletters on error management, e-learning modules to improve team engagement, and interdisciplinary workshops to discuss critical incidents. Survey feedback identified significant improvements in safety climate as well as improvements to incident reporting and learning systems.
Co-worker unprofessional behaviour and patient safety risks: an analysis of co-worker reports across eight Australian hospitals.
Co-worker unprofessional behaviour and patient safety risks: an analysis of co-worker reports across eight Australian hospitals.
https://psnet.ahrq.gov/issue/co-worker-unprofessional-behaviour-and-patient-safety-risks-analysis-co-worker-reports-across
McMullan RD, Churruca K, Hibbert P, et al. Int J Qual Health Care. 2024;36(2).
Unprofessional behavior negatively impacts teamwork, safety culture, and patient safety. This study analyzed 1,310 reports of unprofessional behavior across eight Australian hospitals between 2017-2020. The researchers found that three in ten reports indicated a risk to patient safety, such as interruptions, poor handover communication, and a lack of adherence to hospital policy or protocol.
Judgment errors in surgical care. May 1, 2024
https://psnet.ahrq.gov/issue/judgment-errors-surgical-care
Judgment errors in surgical care.
Marsh KM, Turrentine FE, Jin R, et al. J Am Coll Surg. 2024;238(5):874-879.
Knowing when judgment errors are more likely to occur can increase surgeons' awareness before, during, and after procedures. This study examined the records of 131 patients with 30-day morbidity or mortality to identify any errors in judgment that may have contributed to harm. Examples of errors in judgment included inappropriate operation, premature discharge, and premature removal of drain. Most errors occurred post-operatively (including after discharge) and in colorectal and hepatobiliary procedures.
Transcript for the Biomarker-driven Drug Development for Allergic Diseases and Asthma Public Workshop
Management of Suicidal Thoughts and Behaviors in Youth
Management of Suicidal Thoughts and Behaviors in Youth: This systematic review will assess the effectiveness, comparative effectiveness, and harms of treatments for suicidal thoughts and behaviors in youths. If evidence is available, we will also assess how differences in effectiveness and harms are influenced by components of psychosocial treatments, and patient and environmental characteristics. This work will be used by the American Psychological Association to develop a new clinical practice guideline on this topic.
The Effect of Protein Intake on Health: A Systematic Review
The Effect of Protein Intake on Health: A Systematic Review: This report reviews the association between dietary protein intake and bone disease, kidney disease, and sarcopenia risks, aiming to inform updates to the protein DRIs, including a new reference value for chronic disease risk reduction.
Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review
Evaluation of Dietary Protein and Amino Acid Requirements: A Systematic Review: This report reviews the evidence on the average daily dietary protein and individual indispensable amino acid intake requirement of apparently healthy individuals by life stage and sex. We considered evidence published since the current DRIs were set and our findings will serve as a key reference for future updates to the DRIs for protein and amino acids.
Long COVID Models of Care
Long COVID Models of Care: The purpose of this Technical Brief is to summarize definitions of long COVID and describe what is known about long COVID models of care, including models currently in use, promising approaches, advantages and disadvantages of models in different populations and settings, barriers and facilitators to implementation, access and equity issues, and needed research.
viernes, 3 de mayo de 2024
Revisions to Federal Standards for Collecting and Reporting Data on Race and Ethnicity: What are They and Why do They Matter? Drishti Pillai and Samantha Artiga Published: Apr 30, 2024
Revisions to Federal Standards for Collecting and Reporting Data on Race and Ethnicity: What are They and Why do They Matter?
Drishti Pillai and Samantha Artiga
Published: Apr 30, 2024
https://www.kff.org/racial-equity-and-health-policy/issue-brief/revisions-to-federal-standards-for-collecting-and-reporting-data-on-race-and-ethnicity-what-are-they-and-why-do-they-matter/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-98ackdep6kVCb7PDITndkr0PBjYkth0qW8MLznRRUMru1gkmTFBMq7RBsTKoaXQMqCwwzNT8Hva0zi5cnSMRfSrm0_MA&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
Five Facts About Older Adults’ Health Care Experiences by Race and Ethnicity
Liz Hamel, Ana Gonzalez-Barrera, Marley Presiado, Nancy Ochieng, Juliette Cubanski, and Tricia Neuman
Published: Apr 29, 2024
https://www.kff.org/racial-equity-and-health-policy/issue-brief/older-adults-health-care-experiences-by-race-ethnicity/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--DcHREMuQN8DwWg5bury0JZtTwkngxPyGUTmsDFgfLxFRdRhx1ultcm77UjbG4DnXSC66GWfMCASLBorCltpoiNDE6sw&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
Final Prior Authorization Rules Look to Streamline the Process, but Issues Remain
Kaye Pestaina, Justin Lo, Rayna Wallace, and Michelle Long
Published: May 02, 2024
https://www.kff.org/private-insurance/issue-brief/final-prior-authorization-rules-look-to-streamline-the-process-but-issues-remain/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_tcVRi8h1jcUBZjLYVEDC4w_F9nlS8LSwTN5KQ0XzyRjyOL2g1xpmVSlgbztfFR3EqeWeh_l60XyFsX4s0cFbYbvW5Yg&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
Coverage of Sexual and Reproductive Health Services in Medicare Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, and Alina Salganicoff Published: Apr 30, 2024
Coverage of Sexual and Reproductive Health Services in Medicare
Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, and Alina Salganicoff
Published: Apr 30, 2024
https://www.kff.org/medicare/issue-brief/coverage-of-sexual-and-reproductive-health-services-in-medicare/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--DnM8bdDM6N68KnouO98G7SOm1nwdspcj4ff1sJs7IMBw0WL4PI6X2hbJyX5jx3lY5rUdCB8_aICfsQd7uo_k7xT4Fzw&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
10 Key Facts About Women with Medicare
Meredith Freed, Juliette Cubanski, Michelle Long, Nancy Ochieng, Tricia Neuman, and Alina Salganicoff
Published: Apr 30, 2024
https://www.kff.org/medicare/issue-brief/10-key-facts-about-women-with-medicare/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_Y6DZMGVZQ2XuSbq-8vhG6XuEuzUXDw-XIcMtS66HElM_9ihfhr6ykeAB4zxL5f4yYmklD1nOK664H_Jyp9YmOZN98jQ&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
State Health Coverage for Immigrants and Implications for Health Coverage and Care Akash Pillai, Drishti Pillai, and Samantha Artiga Published: May 01, 2024
https://www.kff.org/racial-equity-and-health-policy/issue-brief/state-health-coverage-for-immigrants-and-implications-for-health-coverage-and-care/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz-_XiHKtfKnU3BYuAxC7fLj157mPKB0QlMCZNofWXLr-bfS-DGHFQEBig1DulnFnV4fz89dEaWn8K7QocwUEKjsQX15sbQ&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
California Floats Extending Health Insurance Subsidies to All Adult Immigrants
By Jasmine Aguilera, El Tímpano
MAY 3, 2024
https://kffhealthnews.org/news/article/california-legislation-medicaid-subsidies-all-adult-immigrants/?utm_campaign=KFF-This-Week&utm_medium=email&_hsenc=p2ANqtz--_X0w3GEcDZduratexdJvB3paS9JnaYizFWVYAXlZNyoym_DT2RLCAtwo7mx_GainuIcQY5O2N49a_KzmNvL_uLA8Y6g&_hsmi=305505167&utm_content=305505167&utm_source=hs_email
FDA Grand Rounds: Whole Genome Sequencing: A Powerful Scientific Tool that Delivered During the 2023 Pseudomonas Outbreak in Eye Drops Thursday, May 9, 2024 12:00 p.m. - 1:00 p.m. ET WebcastFDA Grand Rounds: Whole Genome Sequencing: A Powerful Scientific Tool that Delivered During the 2023 Pseudomonas Outbreak in Eye Drops Thursday, May 9, 2024 12:00 p.m. - 1:00 p.m. ET Webcast
https://www.fda.gov/science-research/about-science-research-fda/fda-grand-rounds?utm_medium=email&utm_source=govdelivery
Title: FDA Grand Rounds - Whole Genome Sequencing: A Powerful Scientific Tool that Delivered During the 2023 Pseudomonas Outbreak in Eye Drops
Date: Thursday, May 9, 2024
Time: 12:00 pm - 1:00 pm ET
Webcast
About the Speaker:
Michelle Cockrell, B.S.
Microbiologist
Office of Regulatory Affairs
Irvine Medical Products Laboratory
U.S. Food and Drug Administration
Michelle Cockrell received her undergraduate degree in Microbiology from the University of Oklahoma in 2017. She worked as a clinical microbiologist and molecular biologist for the Oklahoma State Department of Health where she developed an interest in whole genome sequencing and its significance as a tool for public health. In 2021, she moved to Irvine, California to start her career with the Food and Drug Administration. Now, she works as a microbiologist and lead for the whole genome sequencing workgroup for the Irvine Medical Products Laboratory.
About the Presentation:
Whole Genome Sequencing has been used in FDA’s Human and Animal Food Laboratories for several years, but what about in the medical products laboratories? This presentation will discuss the application of this method as an additional analysis used during the 2023 Pseudomonas outbreak in eye drop products. ORS’ collaboration with the CDC and CFSAN partners led to key information that linked the outbreak strain to the implicated products, providing a scientific basis for FDA to pursue regulatory action.
Using Smart Devices to Implement an Evidence-based eHealth System for Older Adults
https://digital.ahrq.gov/ahrq-funded-projects/using-smart-devices-implement-evidence-based-ehealth-system-older-adults
Enhancing an evidence-based electronic health intervention, Elder Tree, with voice-controlled technology can broaden its use, leading to improved overall health and reduced hospital readmission for older adults with multiple chronic conditions.
Using Digital Healthcare Technologies to Engage and Care for Older Patients
Promoting health and disease prevention is key to staying healthy as people age. Older adults are increasingly using telehealthcare, smartphone apps, and other digital healthcare technologies to access care, maintain patient-provider communication, and promote chronic disease self-management.
During Older Adults Month, the AHRQ Digital Healthcare Research Program (DHR) is recognizing the vital importance of making older adults’ health and wellbeing a priority. Below is a sample of AHRQ-funded research that aims to improve care and health outcomes for older adults through digital healthcare technologies.
TELE-TOC Telehealth Education Leveraging Electronic Transitions of Care for COPD Patients
https://digital.ahrq.gov/ahrq-funded-projects/tele-toc-telehealth-education-leveraging-electronic-transitions-care-copd-patients
Virtual visits with members of a pharmacy team can support patients recently discharged from the hospital with their medication use and improve outcomes among chronic obstructive pulmonary disease patients at high risk for readmission.
Patient-Centered Diabetes Education as an Integral Part of an Electronic Clinic Note using the SEE-Diabetes Modules
https://digital.ahrq.gov/ahrq-funded-projects/patient-centered-diabetes-education-integral-part-electronic-clinic-note
The use of SEE-Diabetes, a user-centered shared decision-making module, may improve self-care behaviors and outcomes for older adults with diabetes
Scalable Digital Communication Intervention to Support Older Adults and Care Partners Transitioning Home After Major Surgery
https://digital.ahrq.gov/ahrq-funded-projects/scalable-digital-communication-intervention-support-older-adults-and-care
Creating a mobile application to support care transitions for older adults after surgery has the potential to provide timely post-discharge information and allow for caregiver preparedness, better health outcomes, and improved communications between providers and patients and their care partner.
The End* of a Long and Winding Road: FDA Publishes Final LDT Rule (*Or Is It?) By Jeffrey N. Gibbs & Allyson B. Mullen —
https://www.thefdalawblog.com/2024/05/the-end-of-a-long-and-winding-road-fda-publishes-final-ldt-rule-or-is-it/?utm_source=rss&utm_medium=rss&utm_campaign=the-end-of-a-long-and-winding-road-fda-publishes-final-ldt-rule-or-is-it
On April 29, 2024, FDA announced its finalization of the laboratory developed test (LDT) rule. The final rule will be published in the Federal Register on Monday May 6, 2024 (here). The final rule marks another milestone in the more than three decades long battle over LDTs. FDA notes that it received over 6,500 comments on the proposed rule. Showing how motivated FDA was to quickly finalize the rule, the Agency claims to have reviewed and addressed all major issues they raised in less than 5 months.
jueves, 2 de mayo de 2024
Dobbs-era Abortion Bans and Restrictions: Early Insights about Implications for Pregnancy Loss Usha Ranji, Alina Salganicoff, and Laurie Sobel Published: May 02, 2024
https://www.kff.org/womens-health-policy/issue-brief/dobbs-era-abortion-bans-and-restrictions-early-insights-about-implications-for-pregnancy-loss/?utm_campaign=KFF-Womens-Health-Policy&utm_medium=email&_hsenc=p2ANqtz--66CYjLg-F9RwlkiRn7aGyLVfvkDDiDhTSqafEYKmJ1EoCAw-DgS18RdlrIIppY7hWcFQtEmPD4TQoTrQ6L1x6yW49wA&_hsmi=305336469&utm_content=305336469&utm_source=hs_email
KFF Examines Implications of Dobbs-era Abortion Bans and Restrictions for Miscarriage or Stillbirth
In a new brief, KFF explores how abortion bans and restrictions in the aftermath of the Supreme Court’s 2022 Dobbs decision can further complicate pregnancy loss.
Pregnancy loss, which includes miscarriage and stillbirth, is common, and for many people, it is a physically, mentally, and emotionally taxing experience. The medical interventions used to manage miscarriages and stillbirths are often the same medicines and procedures used in abortions, which means abortion bans and restrictions can end up limiting care for pregnancy loss.
Further, the threat of criminalization and penalties for clinicians who provide abortions in states with bans can create a chilling effect on clinical care. Four in 10 OBGYNs who practice in states with abortion bans report that management of miscarriages and pregnancy-related emergencies has become worse since the Dobbs ruling.
While all state abortion bans have exceptions for cases of life endangerment of the pregnant person, they don't account for the wide range of circumstances people may face when experiencing a pregnancy loss. Meanwhile, the growing record of documented cases of people experiencing pregnancy-related emergencies who have been denied care highlights what abortion restrictions can mean for pregnancy loss management.
Save the Date – SAMHSA-funded 2024 First Episode Psychosis Conference June 5 & 6, 2024, 10 a.m. – 5 p.m. ET
https://mhttcnetwork.org/south-southwest-mhttc-first-episode-psychosis-conference-2024/?utm_source=SAMHSA&utm_campaign=29596b0f4e-EMAIL_CAMPAIGN_2024_04_18_02_19_COPY_01&utm_medium=email&utm_term=0_-ee4a236fb4-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
The SAMHSA-funded First Episode Psychosis (FEP) Virtual Conference 2024 will bring together stakeholders with a commitment to improving and growing FEP services in the United States. The 2024 theme, Pausing with Purpose: Guiding FEP Care with Human Connection, focuses on the crucial role of human connection in effective FEP care. The theme underscores the importance of fostering genuine relationships among those involved in FEP care, including team members, young people in services, family, and other supporters. Who Should Attend: Those committed to transforming FEP care, including providers, researchers, and those with lived experience.
Get Involved in National Prevention Week Virtual Events May 12 – 18, 2024 — A Celebration of Possibility!
https://www.samhsa.gov/prevention-week?utm_source=SAMHSA&utm_campaign=4ecab52f20-EMAIL_CAMPAIGN_2024_04_15_03_34&utm_medium=email&utm_term=0_-4ecab52f20-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
National Prevention Week is a public education platform showcasing the work of communities and organizations across the country that are preventing substance use and promoting positive mental health. Learn more about how you can get involved throughout the week and register for the events taking place. You can help amplify the power of prevention leading up to National Prevention Week and beyond by sharing your #MyPreventionStory on social media, downloading our planning toolkit, and spreading the word about National Prevention Week.
Biden-Harris Administration Releases National Strategy for Suicide Prevention and First-Ever Federal Action Plan
https://www.samhsa.gov/newsroom/press-announcements/20240423/biden-harris-administration-releases-national-strategy-suicide-prevention-first-ever-federal-action-plan?utm_source=SAMHSA&utm_campaign=65d36b60f1-EMAIL_CAMPAIGN_2024_04_23_05_26&utm_medium=email&utm_term=0_-65d36b60f1-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
The Biden-Harris Administration, through the U.S. Department of Health and Human Services (HHS).released the 2024 National Strategy for Suicide Prevention (National Strategy) and accompanying Federal Action Plan. SAMHSA and the Centers for Disease Control and Prevention (CDC), in partnership with the National Action Alliance for Suicide Prevention (Action Alliance), led the development of these critical products. The National Strategy outlines concrete recommendations for addressing gaps and meeting the needs of at-risk populations. It is accompanied by the first-ever Federal Action Plan, which identifies 200 discrete actions to be initiated and evaluated over the next three years. Actions include, for example, identifying ways to address substance use and suicide risk together in the clinical setting, funding a mobile crisis locator for use by 988 crisis centers, increasing support for survivors of suicide loss and others whose lives have been impacted by suicide, and evaluating promising community-based suicide prevention strategies.
Mental Health Awareness Month
https://www.samhsa.gov/mental-health-awareness-month?utm_source=SAMHSA&utm_campaign=e9b35fda3d-EMAIL_CAMPAIGN_2024_04_12_06_58&utm_medium=email&utm_term=0_-e9b35fda3d-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Join SAMHSA as we raise awareness that mental health affects everyone, at every stage of life. With the right care, we all can thrive, achieve well-being, and live meaningful lives. Check out our Mental Health Awareness Month Toolkit for resources you can use, including social media posts in English and Spanish and shareables—static graphics, animations, and weekly themes—that can be customized and/or shared across platforms to highlight #MHAM2024.
SAMHSA’s National Training and Technical Assistance Center for Early Serious Mental Illness (ESMI TTA Center) Newsletter
https://mailchi.mp/7b758dfa8ea3/national-training-and-technical-assistance-center-for-early-serious-mental-illness-april-newsletter?e=1162024328&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
The ESMI TTA Center is a new national training and technical assistance center funded by SAMHSA to address early serious mental illness (ESMI). The ESMI TTA Center provides education, training, and technical assistance on evidence-based, evidence-informed, and promising practices related to the identification, assessment, and treatment of ESMI.
Behavioral Health Barometers, Region 1-10, Volume 7: Indicators as Measured in the 2021-2022 National Surveys on Drug Use and Health
https://store.samhsa.gov/product/behavioral-health-barometers-volume-7/pep24-07-007?utm_source=SAMHSA&utm_campaign=604b2080ba-EMAIL_CAMPAIGN_2024_04_24_01_48&utm_medium=email&utm_term=0_-604b2080ba-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
SAMHSA has posted the Behavioral Health Barometers, Regions 1-10, Volume 7: Indicators as Measured in the 2021-2022 National Surveys on Drug Use and Health. The report series provides the latest available state-level data on substance use and mental health throughout ten regions spanning the U.S.
Mental Health Client-Level Data (MH-CLD) 2022: Data on Clients Receiving Mental Health Treatment Services Through State Mental Health Agencies
https://store.samhsa.gov/product/mental-health-client-level-data-2022/pep24-07-017?utm_source=SAMHSA&utm_campaign=25be5d20b8-EMAIL_CAMPAIGN_2024_04_29_12_59&utm_medium=email&utm_term=0_-25be5d20b8-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
SAMHSA recently released the 2022 Mental Health Client-Level Data (MH-CLD) Annual Report, which details the total number of clients receiving mental health treatment services in 2022 by demographics, National Outcome Measures, top five mental health diagnoses for children (ages 0-17) and adults (ages 18 and older) by geographic distribution. The report additionally includes a summary of client characteristics for the 2018-2022 reporting periods. The MH-CLD Annual Report is released with public-use files in SAS, SPSS, STATA, R and ASCII comma-delimited formats that are available to the general public. To download public-use files and codebooks, please visit Mental Health Client-Level Data 2022 (MH-CLD-2022-DS0001). Frequently Asked Questions about the MH-CLD are also available.
https://www.datafiles.samhsa.gov/dataset/mental-health-client-level-data-2022-mh-cld-2022-ds0001?utm_source=SAMHSA&utm_campaign=25be5d20b8-EMAIL_CAMPAIGN_2024_04_29_12_59&utm_medium=email&utm_term=0_-25be5d20b8-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
It’s Okay to Not Be Okay: Tips and Resources for Mental Health Awareness Month By: Anita Everett, M.D. DFAPA, Director of the Center for Mental Health Services
https://www.samhsa.gov/blog/its-okay-not-be-okay-tips-resources-mental-health-awareness-month?utm_source=SAMHSA&utm_campaign=6572e41800-EMAIL_CAMPAIGN_2024_04_25_04_50&utm_medium=email&utm_term=0_-6572e41800-%5BLIST_EMAIL_ID%5D&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
It’s May, so just checking in… “How is everybody doing?”
In case you missed it, Sesame Street’s lovable Elmo posed that very question on social media earlier this year – and the responses came flooding in. From relationship problems to financial troubles, and feelings of exhaustion, angst, loneliness, and disconnection, people shared their struggles. At last count, Elmo’s post had garnered more than 217 million views, 15,000 reposts, 165,000 likes, and 45,000 responses on one social media platform alone. What this helps reveal is that many of us are NOT okay – and it’s important to acknowledge and address that, and make sure people know that help is available. SAMHSA has several supports and resources that can help.
On-the-Spot: Hybrid Service Delivery — Virtual TA Session Friday, May 17, 2024 12 p.m. ET
https://attcnetwork.org/event/on-the-spot-hybrid-service-delivery-4/?utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Hybrid service delivery is a mixture of in-person sessions with videoconferencing sessions and may include phone check-ins. Hybrid service delivery models are known for providing flexibility, especially to clients with access issues, such as clients living in rural areas or those with transportation issues. Join the online consultation session every third Friday of the month to ask questions and discuss/share hybrid service delivery tips for practitioners. Examples of topics that can be discussed include how to determine the right combination/ratio of virtual and in-person sessions; leveraging in-person and virtual (video and phone) sessions; negotiating a schedule with clients that will increase engagement, attendance, and adherence to treatment; what clinicians and administrators need to consider when initiating hybrid delivery services (e.g., reimbursement, privacy/security issues, staffing, telephone policies)
Lithium in Pregnancy: Too Much or Not Enough of a Good/Bad Thing? — Webinar Friday, May 17, 2024 12 p.m. ET
https://education.smiadviser.org/Public/Catalog/Details.aspx?id=i9xTkd4zCB2MlUIKCbgRlg%3d%3d&returnurl=%2fUsers%2fUserOnlineCourse.aspx%3fLearningActivityID%3di9xTkd4zCB2MlUIKCbgRlg%253d%253d&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
There are many concerns about the safety of lithium use during pregnancy. In patients who are pregnant and stable on the medication, is it better to risk maintaining the medication through the pregnancy, or change to a potentially "safer" alternative? What about after the pregnancy if the patient is breastfeeding the newborn? This webinar will present data on what the risks to both patient and baby might be throughout the pregnancy and into the postpartum/lactation period, and how this information might be used to educate patients to determine an appropriate course of action.
Nutrition and Perinatal Mental Health: The Importance of Maternal Diet for Mother and Child’s Mental Health — Webinar Wednesday, May 15, 2024 2 p.m. ET
https://mhttcnetwork.org/event/nutrition-and-perinatal-mental-health-the-importance-of-maternal-diet-for-mother-and-childs-mental-health/?utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Review the increased nutritional needs of pregnancy and lactation. Learn about obstacles to achieving optimal dietary intake during pregnancy and after birth. Explore the link between worsened mental health and poor or limited dietary intake in mothers and infants. Describe some steps clinicians can take to support people during the perinatal period through the lens of nutrition.
Stigma and Substance Use Prevention Part 1: The Impacts of Stigma — Webinar Tuesday, May 14, 2024 1 p.m. ET
https://pttcnetwork.org/event/stigma-and-substance-use-prevention-part-1-the-impacts-of-stigma-2/?utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
This webinar will provide a broad overview of stigma and the importance of addressing it through what the research says and what is known through lived experience. The webinar will define stigma and explain how it can manifest in various substance use prevention settings and on the road to recovery. It will address the similarities and differences between public-, self-, and institutional-stigma and the role of both intentional and inadvertent stigma. The webinar will also discuss how stigma impacts substance use prevention outcomes and people’s ability to recover.
Part 2, What Prevention Professionals and Others Can Do, takes place Thursday, May 16 at 1 p.m. ET.
Compassion Fatigue as a Behavioral Health Professional Thursday, May 9, 2024 12:30 p.m. ET
https://mhttcnetwork.org/event/compassion-fatigue-as-a-behavioral-health-professional/?utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Learn to recognize signs of compassion fatigue and secondary trauma – both subtle and overt – and strategies to address them, as well as ongoing practices to care for your sense of self and connection to community in the face of emotionally challenging work.
Opioid Prescribing by Dentists and Oral Maxillofacial Surgeons — Webinar Wednesday, May 8, 2024 5 p.m. ET
https://education.aoaam.org/Public/Catalog/Details.aspx?id=J9lVtwEITjM%2fnAmZdWn3sg%3d%3d&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
This course will give an overview of trends and trajectories of opioid prescribing by dentists and oral and maxillofacial surgeons (OMFS) in the US. Further, we will describe the consequences of opioid prescribing for dental procedures.
Understanding Addiction and Options for Care — Webinar Wednesday, May 8, 2024 11 a.m. ET
https://mhttcnetwork.org/event/understanding-addiction-and-options-for-care/?utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Anyone who has tried to help a loved one obtain treatment for a substance use disorder knows how challenging it can be to find quality, affordable care that’s accessible when someone is ready for help. This workshop will help educate participants about treatment options for opioid, stimulant and other substance use disorders and how to overcome barriers to care. We’ll discuss factors to consider for treatment referrals, resources to connect people with peer support, and how services are evolving to support families and offer person-centered, trauma-informed care.
On-the-Spot: Motivational Interviewing — Virtual TA Session Monday, May 6, 2024 5 p.m. ET
https://attcnetwork.org/event/on-the-spot-motivational-interviewing-26-copy/?preview_id=27538&utm_source=SAMHSA&utm_campaign=19b30702d1-EMAIL_CAMPAIGN_2024_04_30_04_13&utm_medium=email&utm_term=0_-19b30702d1-%5BLIST_EMAIL_ID%5D
Motivational Interviewing (MI) On-the-Spot offers an opportunity to enhance practitioners’ skills and confidence in the utilization and integration of MI into practice by providing access to subject matter experts to obtain immediate feedback during a one-hour, online, open forum. Bring your questions and join in on the dialogue to increase MI knowledge and change clinical practice approaches through the utilization of an MI style of communication.
Hospital Survey on Patient Safety Culture
Hospital Survey on Patient Safety Culture: The Hospital SOPS asks providers and staff for their opinions about the culture of patient safety in their hospitals.
Workplace Safety Supplemental Item Set for Hospital SOPS
Workplace Safety Supplemental Item Set for Hospital SOPS: The SOPS® Workplace Safety Supplemental Items for the Hospital Survey were developed and pilot tested for use with the core SOPS Hospital Survey to help hospitals assess the extent to which their organization’s culture supports workplace safety for providers and staff.
Listening to the Voice of the Patient: Using Multiple Feedback Methods to Complement CAHPS Survey Data
Listening to the Voice of the Patient: Using Multiple Feedback Methods to Complement CAHPS Survey Data: The webinar will discuss how patient experience professionals use multiple feedback methods to fully capture the patient voice. Speakers will describe how additional feedback methods complement CAHPS data, and how this integration of data sources informs their efforts to identify improvement areas and potential solutions.
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast)
Using AHRQ’s SOPS® Hospital Survey and Workplace Safety Item Set: Experiences From a State Hospital Association (Webcast): This webcast discussed Indiana Hospital Association’s experiences using the Surveys on Patient Safety Culture® (SOPS®) Hospital Survey and Workplace Safety Item Set. They shared their member organizations’ survey results, how SOPS resources were used, and their focus on initiatives to address workplace safety, including burnout. Recent research about the relationship between hospital workplace safety and patient safety culture, job satisfaction, and intent to leave was also shared.
AHRQ Impact Case Studies
AHRQ Impact Case Studies
AHRQ’s evidence-based tools and resources are used by organizations nationwide to improve the quality, safety, effectiveness, and efficiency of health care. The Agency’s Impact Case Studies highlight these successes, describing the use and impact of AHRQ-funded tools by State and Federal policy makers, health systems, clinicians, academicians, and other professionals.